HomeREGULATORY
REGULATORY

Global Headquarters Watching Japan, Keep Drug Prices for Patented Period: PhRMA, EFPIA
(May.19.2017)

EFPIA Japan Chairman Ole Moelskov Bech (left), PhRMA Japan-Chief Patrik Jonsson
The headquarters of global drug makers are keeping a close eye on whether the Japanese government will carry on its pro-innovation policies to maintain drug prices during the patent term, Japan chairmen of PhRMA and EFPIA stressed on May 18 ...
(LOG IN FOR FULL STORY)

News Calendar